Market closedNon-fractional

Bausch Health/BHC

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Bausch Health

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Ticker

BHC

Sector

Healthcare

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Laval, Canada

Employees

20,270

Bausch Health Metrics

BasicAdvanced
$2.6B
Market cap
-
P/E ratio
-$1.25
EPS
0.86
Beta
-
Dividend rate
$2.6B
0.86
1.225
0.631
-12,377.011
-12,686.207
1.22%
4.04%
3,303.45%
0.29
-2.34
-0.14
3.31
10.01%
26.35%
3.69%
-24.26%

What the Analysts think about Bausch Health

Analyst Ratings

Majority rating from 4 analysts.
Hold

Bausch Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2.97% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.2B
-10.59%
Net income
-$64M
64.10%
Profit margin
-2.97%
84.47%

Bausch Health Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 16.39%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.82
$1.02
$1.15
$0.60
-
Expected
$0.76
$0.90
$1.00
$0.72
$0.88
Surprise
7.61%
13.92%
14.50%
-16.39%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bausch Health stock?

Bausch Health (BHC) has a market cap of $2.6B as of July 04, 2024.

What is the P/E ratio for Bausch Health stock?

The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of July 04, 2024.

Does Bausch Health stock pay dividends?

No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Bausch Health dividend payment date?

Bausch Health (BHC) stock does not pay dividends to its shareholders.

What is the beta indicator for Bausch Health?

Bausch Health (BHC) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Bausch Health stock

Buy or sell Bausch Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing